A Sensitive Method to Quantify Human Long DNA in Stool: Relevance to Colorectal Cancer Screening
Open Access
- 1 June 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 15 (6), 1115-1119
- https://doi.org/10.1158/1055-9965.epi-05-0992
Abstract
Human long DNA in stool may reflect nonapoptotic exfoliation and has been used as a colorectal cancer (CRC) marker. Targeting human-specific Alu repeats represents a logical but untested approach. A real-time Alu PCR assay was developed for quantifying long human DNA in stool and evaluated in this study. The accuracy and reproducibility of this assay and the stability of long DNA during room temperature fecal storage were assessed using selected patient stools and stools added to human DNA. Thereafter, long DNA levels were determined in blinded fashion from 18 CRC patients and 20 colonoscopically normal controls. Reproducibility of real-time Alu PCR for quantifying fecal long DNA was high (r2 = 0.99; P < 0.01). Long DNA levels in nonbuffered stools stored at room temperature fell a median of 75% by 1 day and 81% by 3 days. An EDTA buffer preserved DNA integrity during such storage. Human long DNA was quantifiable in all stools but was significantly higher in stools from CRC patients than from normal controls (P < 0.05). At a specificity of 100%, the sensitivity of long DNA for CRC was 44%. Results indicate that real-time Alu PCR is a simple method to sensitively quantify long human DNA in stool. This study shows that not all CRCs are associated with increased fecal levels of long DNA. Long DNA degrades with fecal storage, and measures to stabilize this analyte must be considered for optimal use of this marker. (Cancer Epidemiol Biomarkers Prev 2006;15(6):1115–9)Keywords
This publication has 20 references indexed in Scilit:
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Fecal DNA versus Fecal Occult Blood for Colorectal-Cancer Screening in an Average-Risk PopulationNew England Journal of Medicine, 2004
- Analysis of Early Human Immunodeficiency Virus Type 1 DNA Synthesis by Use of a New Sensitive Assay for Quantifying Integrated ProvirusJournal of Virology, 2003
- DNA Integrity as a Potential Marker for Stool-based Detection of Colorectal CancerClinical Chemistry, 2003
- Detection ofAPCMutations in Fecal DNA from Patients with Colorectal TumorsNew England Journal of Medicine, 2002
- Universal detection of aerodigestive cancers by assay of nonapoptotic human DNA in stoolGastroenterology, 2000
- A method for preparation of fecal DNA suitable for PCRNucleic Acids Research, 1995
- Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult BloodNew England Journal of Medicine, 1993
- Identification of ras Oncogene Mutations in the Stool of Patients with Curable Colorectal TumorsScience, 1992
- Revision of consensus sequence of human Alu repeats — a reviewGene, 1987